“Production of Lentivirus Particles Pseudotyped With SARS-CoV-2 Spike Protein for Neutralisation or Drug Antiviral Activity Assays”. One Health & Risk Management (December 13, 2023): 77. Accessed July 10, 2026. https://ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/657.